|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 07:19AM
|
|
Re: Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 02:52PM
|
|
Re: Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 05:26PM
|
|
Re: Aducanumab and the amyloid beta hypothesis is not dead yet!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 22, 2019 10:52AM
|
|
Re: AE/LFT concerns
|
6
|
Resverlogix Corp.
|
Nov 16, 2019 06:56PM
|
|
Re: AE/LFT concerns
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 08:51PM
|
|
Re: AEGIS-II trial
|
5
|
Resverlogix Corp.
|
Mar 22, 2018 08:20PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 24, 2018 07:24AM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 22, 2018 01:06PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 22, 2018 01:29PM
|
|
Re: After the dust settles in 3 weeks
|
4
|
Resverlogix Corp.
|
Nov 09, 2015 10:46AM
|
|
Re: Age, MoCA and CKD
|
6
|
Resverlogix Corp.
|
Nov 19, 2019 03:15PM
|
|
Re: Age, MoCA and CKD
|
6
|
Resverlogix Corp.
|
Nov 18, 2019 06:00PM
|
|
Re: Age, MoCA and CKD
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 06:44PM
|
|
Re: Age, MoCA and CKD
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 12:24PM
|
|
Re: Age, MoCA and CKD
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 08:00PM
|
|
Re: Age, MoCA and CKD
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 01:14PM
|
|
Re: Age, MoCA and CKD
|
|
Resverlogix Corp.
|
Dec 06, 2019 01:32PM
|
|
Re: Age, MoCA and CKD
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 01:49PM
|
|
Re: Age, MoCA and CKD
|
1
|
Resverlogix Corp.
|
Nov 19, 2019 09:05AM
|
